DITROPAN oxybutynin hydrochloride 5mg tablet

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3d8d9dc15c6a3e40
Product Name: DITROPAN oxybutynin hydrochloride 5mg tablet
Artg Id: 48965
Artg Name: DITROPAN oxybutynin hydrochloride 5mg tablet bottle
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 1994-05-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-05879-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-05878-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3d8d9dc15c6a3e40

Type

Standard